Uma Giri

5.3k total citations
51 papers, 1.6k citations indexed

About

Uma Giri is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Uma Giri has authored 51 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 20 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Uma Giri's work include Cancer-related Molecular Pathways (7 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (5 papers). Uma Giri is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (5 papers). Uma Giri collaborates with scholars based in United States, India and Japan. Uma Giri's co-authors include Mohammad Athar, John V. Heymach, Mohammad Iqbal, Michael D. Story, John S. Yordy, Raymond E. Meyn, Beth M. Beadle, Jeffrey N. Myers, Heath D. Skinner and Kevin R. Coombes and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Uma Giri

51 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Uma Giri United States	23	984	489	472	263	126	51	1.6k
Quintin Pan United States	20	756 0.8×	370 0.8×	739 1.6×	261 1.0×	189 1.5×	40	1.8k
Huei Lee Taiwan	30	1.3k 1.3×	568 1.2×	740 1.6×	393 1.5×	260 2.1×	63	2.1k
Huiling Yang China	26	1.3k 1.3×	542 1.1×	475 1.0×	148 0.6×	150 1.2×	65	1.7k
Keqiang Zhang China	29	1.2k 1.2×	682 1.4×	456 1.0×	267 1.0×	109 0.9×	75	1.9k
Sun Young Yoon South Korea	18	816 0.8×	295 0.6×	319 0.7×	162 0.6×	154 1.2×	56	1.3k
Stina Garvin Sweden	17	734 0.7×	295 0.6×	633 1.3×	114 0.4×	107 0.8×	25	1.4k
Li‐Xi Yang United States	18	1.1k 1.1×	246 0.5×	512 1.1×	215 0.8×	210 1.7×	35	1.9k
Wenqi Jiang China	19	403 0.4×	168 0.3×	759 1.6×	223 0.8×	148 1.2×	43	1.6k
Chiara Paglino Italy	19	1.3k 1.3×	618 1.3×	769 1.6×	800 3.0×	175 1.4×	46	2.4k

Countries citing papers authored by Uma Giri

Since Specialization

Citations

This map shows the geographic impact of Uma Giri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uma Giri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uma Giri more than expected).

Fields of papers citing papers by Uma Giri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uma Giri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uma Giri. The network helps show where Uma Giri may publish in the future.

Co-authorship network of co-authors of Uma Giri

This figure shows the co-authorship network connecting the top 25 collaborators of Uma Giri. A scholar is included among the top collaborators of Uma Giri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uma Giri. Uma Giri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Soleimani, Milad, Anna Capasso, Uma Giri, et al.. (2023). Elucidating the direct effects of the novel HDAC inhibitor bocodepsin (OKI-179) on T cells to rationally design regimens for combining with immunotherapy. Frontiers in Immunology. 14. 1260545–1260545. 3 indexed citations

Soleimani, Milad, Tamer S. Kaoud, Dennis Wylie, et al.. (2022). Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy. Molecular Cancer Therapeutics. 21(10). 1547–1560. 14 indexed citations

Giri, Uma, et al.. (2022). Dermatomyositis in an Elderly with Respiratory Presentation: A Case Report. SHILAP Revista de lepidopterología. 60(247). 306–309. 1 indexed citations

Sitthideatphaiboon, Piyada, Ana Galan Cobo, Marcelo V. Negrão, et al.. (2020). STK11 /LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition. Clinical Cancer Research. 27(6). 1720–1733. 57 indexed citations

Skinner, Heath D., Uma Giri, Liang Yang, et al.. (2017). Integrative Analysis Identifies a Novel AXL–PI3 Kinase–PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer. Clinical Cancer Research. 23(11). 2713–2722. 86 indexed citations

Wang, Yifan, Jayanthi Gudikote, Uma Giri, et al.. (2017). RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non–small Cell Lung Cancer. Clinical Cancer Research. 24(2). 341–350. 32 indexed citations

Skinner, Heath D., Uma Giri, Liang Yang, et al.. (2016). Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer. Clinical Cancer Research. 22(18). 4643–4650. 55 indexed citations

Nilsson, Monique B., Uma Giri, Jayanthi Gudikote, et al.. (2015). KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib. Clinical Cancer Research. 22(8). 1940–1950. 10 indexed citations

Ferrarotto, Renata, Suk Young Yoo, Pan Tong, et al.. (2015). Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer. Clinical Cancer Research. 22(7). 1674–1686. 40 indexed citations

10.

Fan, You-Hong, Uma Giri, Babita Saigal, et al.. (2015). 8-Chloroadenosine Sensitivity in Renal Cell Carcinoma Is Associated with AMPK Activation and mTOR Pathway Inhibition. PLoS ONE. 10(8). e0135962–e0135962. 15 indexed citations

11.

Lin, Steven H., Jing Zhang, Uma Giri, et al.. (2014). A High Content Clonogenic Survival Drug Screen Identifies MEK Inhibitors as Potent Radiation Sensitizers for KRAS Mutant Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(7). 965–973. 31 indexed citations

12.

Lin, Steven H., Jing Wang, Pierre Saintigny, et al.. (2014). Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial–mesenchymal transition. BMC Genomics. 15(1). 1079–1079. 40 indexed citations

13.

Wagner, Klaus W., Hunain Alam, Shilpa S. Dhar, et al.. (2013). KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling. Journal of Clinical Investigation. 123(12). 5231–5246. 149 indexed citations

14.

Yang, Fei, Ximing Tang, Erick Riquelme, et al.. (2011). Increased VEGFR-2 Gene Copy Is Associated with Chemoresistance and Shorter Survival in Patients with Non–Small-Cell Lung Carcinoma Who Receive Adjuvant Chemotherapy. Cancer Research. 71(16). 5512–5521. 51 indexed citations

15.

Moeller, Benjamin J., John S. Yordy, Michelle D. Williams, et al.. (2011). DNA Repair Biomarker Profiling of Head and Neck Cancer: Ku80 Expression Predicts Locoregional Failure and Death following Radiotherapy. Clinical Cancer Research. 17(7). 2035–2043. 75 indexed citations

16.

Skinner, Heath D., Vlad C. Sandulache, Thomas J. Ow, et al.. (2011). TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence. Clinical Cancer Research. 18(1). 290–300. 222 indexed citations

17.

Koto, Masashi, Oliver Riesterer, Uma Giri, et al.. (2011). Human lymphoma cells develop resistance to radiation in the presence of astrocytes in vitro. Zurich Open Repository and Archive (University of Zurich). 3 indexed citations

18.

Riesterer, Oliver, Fumihiko Matsumoto, Li Wang, et al.. (2009). A novel Chk inhibitor, XL-844, increases human cancer cell radiosensitivity through promotion of mitotic catastrophe. Investigational New Drugs. 29(3). 514–522. 41 indexed citations

19.

Iqbal, Muzaffar, Uma Giri, & Mohammad Athar. (1995). Ferric Nitrilotriacetate (Fe-NTA) Is a Potent Hepatic Tumor Promoter and Acts Through the Generation of Oxidative Stress. Biochemical and Biophysical Research Communications. 212(2). 557–563. 69 indexed citations

20.

Kimler, Bruce F., P.G. Shankar Giri, Uma Giri, & Glendon G. Cox. (1986). Effect of single dose, fractionated, and hyperfractionated trunk irradiation on weight gain, respiration frequency and survival in rats. Europe PMC (PubMed Central). 7. 360–362. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact